HomeMarket NewsThe Disappointing Tale of Cargo Therapeutics stock in Q4 2023 Earnings

The Disappointing Tale of Cargo Therapeutics stock in Q4 2023 Earnings

Actionable Trade Ideas

always free

CRGX stock - Cargo Therapeutics Stock in Q4 2023 Earnings

Source: iQoncept / Shutterstock

Cargo Therapeutics (NASDAQ:CRGX) recently fell short in its earnings report for the final quarter of 2023.

  • Recording an earnings per share of -$1.49, the company missed the mark as analysts had predicted an EPS of -$1.44.
  • Disappointingly, Cargo Therapeutics did not generate any revenue during the quarter.

InvestorPlace Earnings, powered by data from TradeSmith, provides automated coverage of quarterly earnings. Delivering key metrics such as earnings per share and revenue, it also compares company performance against analyst forecasts. These reports are issued promptly, directly informing our readers without manual assistance. To report any issues or discrepancies, reach out to us at editor@investorplace.com.


This article is from InvestorPlace Media, available at https://investorplace.com/earning-results/2024/03/crgx-stock-earnings-cargo-therapeutics-for-q4-of-2023/.

©2024 InvestorPlace Media, LLC

Swing Trading Ideas and Market Commentary

Need some new swing ideas? Get free weekly swing ideas and market commentary from Jonathan Bernstein here: Swing Trading.

Explore More

Weekly In-Depth Market Analysis and Actionable Trade Ideas

Get institutional-level analysis and trade ideas to take your trading to the next level, sign up for free and become apart of the community.